The Impact of Starbright World on Children Being Treated at the NIH
NCT00001816 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 35
Last updated 2008-03-04
Summary
This study seeks to evaluate the impact of Starbright World (SBW) on hospitalized children. SBW is a virtual environment designed to link seriously ill children into an interactive online community where they can play games, learn about their condition, or talk with other ill children who are connected to the network. Our outcome evaluation of SBW will include assessments of pain, mood (anxious, depressed and energetic), anger, loneliness, and willingness to return to the NIH for treatment of children who are being treated at NIH. They will be assessed while engaging in "normal" recreational activities (in one of two available playrooms) and while using Starbright World. In addition, we will conduct a process evaluation of the implementation of Starbright World.
Conditions
- Child, Hospitalized
Sponsors & Collaborators
-
National Cancer Institute (NCI)
lead NIH
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1999-05-31
- Completion
- 2001-02-28
Countries
- United States
Study Locations
More Related Trials
-
Cyclophosphamide, Topotecan, and Bevacizumab (CTB) in Patients With Relapsed/Refractory Ewing's Sarcoma and Neuroblastoma
NCT01492673 ·Status: COMPLETED ·Phase: PHASE2
-
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
NCT05535166 ·Status: RECRUITING ·Phase: PHASE2
-
Therapy for Children With Advanced Stage Neuroblastoma
NCT01857934 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Neuroblastoma
NCT00017368 ·Status: COMPLETED ·Phase: PHASE2
-
Radiation Therapy and the Natural History of Childhood Cancers
NCT00064883 ·Status: COMPLETED
-
A Phase I Study of AdV-tk + Prodrug Therapy in Combination With Radiation Therapy for Pediatric Brain Tumors
NCT00634231 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma
NCT00085735 ·Status: COMPLETED ·Phase: PHASE3
-
Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors
NCT00003141 ·Status: COMPLETED ·Phase: PHASE1
-
Molecular-Guided Therapy for Childhood Cancer
NCT02162732 ·Status: COMPLETED ·Phase: NA
-
Neurobehavioral Complications in Children Who Were Previously Treated With Steroids and Intrathecal Therapy for Acute Lymphoblastic Leukemia
NCT00085176 ·Status: COMPLETED
-
Gene Modified Allogeneic Neuroblastoma Cells For Treatment of Relapsed/Refractory Neuroblastoma
NCT00186862 ·Status: COMPLETED ·Phase: PHASE1
-
Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children With Newly Diagnosed Advanced Medulloblastoma
NCT00003573 ·Status: COMPLETED ·Phase: PHASE2
-
Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma
NCT00002875 ·Status: COMPLETED ·Phase: PHASE3
-
Chemotherapy With or Without Additional Chemotherapy and/or Radiation Therapy in Treating Children With Newly Diagnosed Hodgkin's Disease
NCT00025259 ·Status: COMPLETED ·Phase: PHASE3
-
Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid Tumors
NCT05302921 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy and Surgery Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Neuroblastoma
NCT00024193 ·Status: UNKNOWN ·Phase: PHASE2
-
The PediQUEST Study: Evaluation of Pediatric Quality of Life and Evaluation of Symptoms Technology
NCT01838564 ·Status: COMPLETED ·Phase: NA
-
Busulfan in Treating Children and Adolescents With Refractory CNS Cancer
NCT00006246 ·Status: COMPLETED ·Phase: PHASE1
-
SGT-53 in Children With Recurrent or Progressive CNS Malignancies
NCT03554707 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
A Study to Evaluate Treatment With Nivolumab Alone and Nivolumab Combined With Ipilimumab in Children With Melanoma
NCT06163170 ·Status: COMPLETED
-
Talazoparib Plus Irinotecan With or Without Temozolomide in Children With Refractory or Recurrent Solid Malignancies
NCT02392793 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Systemic and Spinal Chemotherapy Followed by Radiation for Infants With Brain Tumors
NCT00042367 ·Status: COMPLETED ·Phase: NA
-
Gene Therapy in Treating Children With Refractory or Recurrent Neuroblastoma
NCT00002748 ·Status: COMPLETED ·Phase: PHASE1
-
MIBG Therapy for Patients With MIBG Avid Tumors
NCT02378428 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Parent/Child Dyad Approach to Symptom Screening for Children With Cancer
NCT05012917 ·Status: COMPLETED ·Phase: NA